The Role of Eccentric Contraction Training in the Postoperative Rehabilitation of Patients With Total Knee Arthroplasty.

Physiother Res IntSep 23, 2026
Clinical ResearchOrthopedic SurgeryPhysical Medicine & Rehabilitation

Zhaolei Fan, Yu Zhang, XingYan Du et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial investigated the effects of eccentric contraction training on functional recovery in 44 patients post-total knee arthroplasty (TKA). The study found that the ECC-CON group showed significant improvements in the Knee Society Score (KSS) functional score and WOMAC total score compared to the concentric-only group, with p-values less than 0.001 for both outcomes.

Key findings

  • The ECC-CON group had a significant improvement in KSS functional score (p < 0.001).
  • WOMAC total score also improved significantly in the ECC-CON group (p < 0.001).
  • Active range of motion extension showed significant improvement (p = 0.006).
  • VAS pain scores indicated different trajectories of pain reduction favoring the ECC-CON group (p = 0.011).

Why it matters

Understanding the benefits of eccentric training in postoperative rehabilitation can help clinicians optimize recovery strategies for TKA patients, potentially enhancing functional outcomes and patient satisfaction.

Source

PubMed · PMID 42770473

Published in Physiother Res Int. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Orthopedic Surgery

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.